ZENAS BIOPHARMA INC
ZBIONASDAQ🏆 #1799 by market capUS Equity
$31.58▼ $0.84 (−2.65%)
Live1h▲ 1.1%
24h▼ 2.6%
7d▼ 0.9%
14d▲ 1.5%
30d▲ 13.2%
1y▲ 98.2%
🏦Market Cap
$1.99B
Small Cap
📈Revenue Growth (YoY)
+100.0%
High Growth
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
42
Weak
Earnings
Q2 · 2026Reported 2026-05-13Earnings Per Share
Actual
-1.46
Expected
-1.37
miss
−6.60%
YoY −82.50%
Revenue
Actual
—
Expected
$25.00M
—
—
Consensus estimates
Recent quarters
Q2 2026
-1.46
miss
Q1 2026
-1.10
miss
Q4 2025
-1.22
miss
Q3 2025
-1.25
miss